Cancerous disease modifying antibodies
AssigneeHoffman-La Roche Inc.
InventorsDavid S. F. Young, Helen P. Findlay, Susan E. Hahn, Lisa A. Popp
Life of this patent
Estimating the term…
Loading patent…
AssigneeHoffman-La Roche Inc.
InventorsDavid S. F. Young, Helen P. Findlay, Susan E. Hahn, Lisa A. Popp
Estimating the term…
The present invention relates to a method for producing cancerous disease modifying antibodies using a novel paradigm of screening. By segregating the anti-cancer antibodies using cancer cell cytotoxicity as an end point, the process makes possible the production of anti-cancer antibodies for therapeutic and diagnostic purposes. The antibodies can be used in aid of staging and diagnosis of a cancer, and can be used to treat primary tumors and tumor metastases. The anti-cancer antibodies can be conjugated to toxins, enzymes, radioactive compounds, cytokines, interferons, target or reporter moieties and hematogenous cells.
A method for initiating antibody induced cytotoxicity of cancerous cells in a tissue sample selected from a human lung or pancreatic tumor comprising:
Dependencies are inferred from the claim text.